Press Release

View all news

Incyte to Present at Upcoming Investor Conference

May 21, 2024 at 8:00 AM EDT

WILMINGTON, Del.--(BUSINESS WIRE)--May 21, 2024-- Incyte (Nasdaq:INCY) announced today that it will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 8:00 a.m. (EDT) in Miami.

The presentation will be webcast live and can be accessed at and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

Incyte Contacts


Source: Incyte